GeneNews
Oncore Pharma Signs European Marketing Deal for Colorectal Cancer Test
The seven-gene test, ColonSentry, is designed to determine an individual's current risk for colorectal cancer relative to an average risk population.
GeneNews, Oncore Pharma Ink Colorectal Cancer Test Deal
Oncore and its partners will commercialize GeneNews' ColonSentry test in all countries outside the US and Canada under the five-year exclusive agreement
GeneNews Posts 88 Percent Decline in Q2 Revenues; Inks Liquid Biopsy Alliance With LifeX
The company has struck a deal to market its tests, including ones based on its Aristotle early cancer detection platform, in collaboration with LifeX.
GeneNews Partners With AIM Laboratories on Cancer Tests
The companies have signed a deal under which each will make its tests available to the other's customer base.
GeneNews Q1 Revenues Plummet Amid Billing Changes
The company had to halt and later restart billing for its cancer risk assessment tests as it transitioned to a new billing process.
Apr 3, 2018
GeneNews Q4 Revenues Fall 81 Percent
Nov 15, 2017
GeneNews Posts 51 Percent Drop in Q3 Revenues
Nov 9, 2017
GeneNews Closes $10M Financing Agreement
Aug 15, 2017
GeneNews Q2 Revenues Drop 78 Percent
Mar 17, 2017
In Brief This Week: BGI, Agilent, ReadCoor, GeneNews
Mar 9, 2017
GeneNews Settles With HDL Liquidating Trust
Dec 29, 2016
GeneNews Truncates Offering Due to Market Conditions
Sep 2, 2016
GeneNews Closes C$1.6M Private Placement
Jun 9, 2016
GeneNews Lands C$5M Capital Commitment
May 31, 2016
GeneNews 2015 Revenues Collapse Amid Restructuring
Mar 31, 2016